From June 16 to 18, the 24th CPHI China 2026 concluded successfully at the Shanghai New International Expo Center. This year’s event was themed “Pooling Strength for Collaborative Innovation, Smartly Pioneering the Future of Pharmaceuticals,” with an exhibition area exceeding 240,000 square meters. It brought together more than 3,600 exhibitors from around the world and over 110,000 professional visitors, focusing on cutting-edge technologies in the pharmaceutical industry and global market trends, while establishing a hub platform for exchange and cooperation across the entire industrial chain. Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., a subsidiary of Guangyao Group—a Fortune Global 500 company—showcased its core products, engaged in face-to-face discussions with industry partners, explored new opportunities for collaboration, and jointly mapped out a new vision for the industry.
